Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Rotigotine ER by UCB for Frontotemporal Dementia (FTD): Likelihood of Approval
Rotigotine ER is under clinical development by UCB and currently in Phase II for Frontotemporal Dementia (FTD). According to GlobalData,...